IIIM1 is an orally active anti-inflammatory peptide. It alleviates symptoms of experimental autoimmune encephalomyelitis (EAE) by stimulating the proliferation of regulatory T cells and inducing them to produce RA1, which balances cytokine levels. IIIM1 is applicable for research on multiple sclerosis (MS).
Molecular Weight:
1016.11
CAS Number:
[500217-51-6]
Formula:
C44H69N15O13
Target:
Interleukin
TP3937
* VAT and and shipping costs not included. Errors and price changes excepted